Skip to main content
. 2022 May 16;27(3):223–228. doi: 10.6065/apem.2142210.105

Table 5.

Changes in vitamin B12 across time intervals and levels of compliance

Treatment group Vitamin B12 level (pg/mL)
P-value (2-tailed)
Mean±SD MD (95% CI) SED
High dose with good compliance
 Baseline 571.29±137.66 0 N/A N/A
 6 Months 536.44±59.89 -34.84 (-74.17 to 143.85) 50.83 0.504
 12 Months 524.75±125.00 -46.54 (-99.93 to 193.00) 67.80 0.505
 24 Months 429.56±97.06 -141.73 (16.12 to 267.34) 58.56 0.030*
 36 Months 398.75±80.49 -172.54 (48.86 to 296.21) 57.25 0.010*
Low dose with good compliance
 Baseline 507.09±130.68 0 N/A N/A
 6 Months 486.78±137.96 -20.30 (-39.91 to 80.52) 30.25 0.504
 12 Months 521.52±181.34 14.44 (-87.02 to 58.15) 36.45 0.693
 24 Months 488.61±141.19 -18.48 (-44.10 to 81.05) 31.41 0.558
 36 Months 495.48±150.07 -11.61 (-61.27 to 84.48) 36.41 0.751
Low dose with poor compliance
 Baseline 549.83±225.24 0 N/A N/A
 6 Months 539.45±180.51 -10.38 (-167.72 to 188.47) 56.64 0.905
 12 Months 560.42±229.68 10.58 (-203.17 to 182.01) 92.86 0.910
 24 Months 564.90±180.31 15.07 (-162.70 to 132.57) 72.29 0.836
 36 Months 562.58±192.37 12.75 (-190.08 to 164.58) 85.51 0.883

SD, standard deviation; MD, mean difference; CI, confidence interval; SED, standard error difference; N/A, not available.

*

P<0.05, statistically significant differences.